Form 4: Waters Corp Director Richard Fearon Receives Equity Awards

Waters Corp Director Richard Fearon was granted 23 restricted common shares and 57 stock options, vesting in February 2027.

Summary

• Richard H. Fearon, a Director of Waters Corp, acquired 23 shares of common stock on February 25, 2026.
• These common shares were acquired at a price of $0 and are subject to restrictions that will lapse 100% on February 9, 2027.
• Following this transaction, Fearon's direct beneficial ownership of common stock is 2,302 shares.
• Fearon also acquired 57 stock options (right to buy) on February 25, 2026, with an exercise price of $319.44.
• These stock options were acquired at a price of $0 and will vest and become exercisable on February 9, 2027, with an expiration date of February 25, 2036.
• His direct beneficial ownership of derivative securities (stock options) following this transaction is 57.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting routine director compensation and alignment of interests, without indicating significant operational or financial changes.

Positives

• Director Richard H. Fearon received equity awards, which aligns his interests with long-term shareholder value.

Future Outlook

The acquired restricted common stock and stock options are scheduled to vest and become exercisable on February 9, 2027, indicating a future milestone for these equity awards.

Industry Context

StockSavvy.ai notes that equity grants to directors are a standard practice in corporate compensation, aiming to align leadership incentives with long-term company performance and shareholder interests within the scientific instruments and technology sector.

Comparison to Industry Standards

• The grant of restricted stock and stock options to a director is a common compensation practice across industries, including the scientific instruments sector where Waters Corp operates.
• This aligns with typical executive and director incentive structures seen in companies like Thermo Fisher Scientific (TMO) or Agilent Technologies (A), which frequently use equity-based compensation to retain talent and incentivize performance.

Stakeholder Impact

• Shareholders: Increased alignment of the director's interests with long-term shareholder value through equity ownership.

Next Steps

• Restrictions on 23 common shares will lapse on February 9, 2027.
• 57 stock options will vest and become exercisable on February 9, 2027.

Key Dates

Recommendation

This Form 4 details a routine equity grant to a director, which is a standard component of executive compensation designed to align interests with shareholders. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this filing does not present new catalysts for significant price movement.

Keywords

Waters Corp, WAT, Richard Fearon, Form 4, insider transaction, equity award, restricted stock, stock options, director compensation